Archiv der Pharmazie · 2014 · 11 citations · 24 references
Life SciencesMedicinal ChemistryPharmacologyEnzymologyNeuropharmacologyStructure-activity RelationshipsCholinergic NeurochemistryCholinergic PharmacologyCholinergic SignalingEnzyme InhibitionStructure-activity Relationship AnalysisAcetylcholine PharmacologyAcetylcholinesterase FunctionAcetylcholinesterase InhibitorsAche InhibitionButyrylcholinesterase InhibitionHydrolysis
Gypsogenin (1) was obtained by acidic hydrolysis from its saponin. While the parent compound 1 acted as a selective inhibitor for butyrylcholinesterase (from equus) possessing a moderate mixed-type inhibition of the enzyme, Ki values as low as 2.67 ± 0.59 μM were determined for (3β,4α) 3-O-acetyl-olean-12-ene-23,28-dinitrile (11) and acetylcholinesterase (AChE, from electric eel). Thus, 11 possesses one-fifth of the inhibitory activity of the "gold standard" galantamine hydrobromide; this compound is one of the first pentacyclic triterpenoids described as a potent AChE-selective inhibitor.
24
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
The worldwide economic impact of dementia 2010
Anders Wimo, Linus Jönsson, John Bond et al. · Alzheimer s & Dementia · 2013 · 1.1K citations